Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

An Observational Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Previously Injected in the Target Knee Joint of Subjects With Moderately to Severely Symptomatic Osteoarthritis

ClinicalTrials.gov ID: NCT02951026

Public ClinicalTrials.gov record NCT02951026. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 1:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Observational Long-term Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Previously Injected in the Target Knee Joint of Subjects With Moderately to Severely Symptomatic Osteoarthritis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This long-term extension study is designed to monitor the long-term safety, tolerability, and efficacy of treatment of SM04690 or placebo previously injected in the target knee joints of subjects with moderately to severely symptomatic osteoarthritis (OA) from a Samumed-sponsored SM04690-OA phase 2 or phase 3 study. No additional SM04690 or placebo therapy will be administered in this study.

Study identification

NCT ID
NCT02951026
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Biosplice Therapeutics, Inc.
Industry
Enrollment
703 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 19, 2016 (Actual)
Primary completion
Oct 31, 2019 (Actual)
Completion
Oct 31, 2019 (Actual)
Last update posted
Apr 17, 2020

2016 – 2019

United States locations

U.S. sites
62
U.S. states
27
U.S. cities
62
Facility City State ZIP Site status
Research Site Birmingham Alabama — —
Research Site Oro Valley Arizona — —
Research Site Phoenix Arizona — —
Research Site Tucson Arizona — —
Research Site Canoga Park California — —
Research Site Carmichael California — —
Research Site Cerritos California — —
Research Site El Cajon California — —
Research Site Gold River California — —
Research Site La Mesa California — —
Research Site Palm Springs California — —
Research Site Rancho Mirage California — —
Research Site Sacramento California — —
Research Site San Diego California — —
Research Site San Marcos California — —
Research Site Spring Valley California — —
Research Site Boulder Colorado — —
Research Site Stamford Connecticut — —
Research Site Trumbull Connecticut — —
Research Site Waterbury Connecticut — —
Research Site Clearwater Florida — —
Research Site Coral Gables Florida — —
Research Site DeLand Florida — —
Research Site Edgewater Florida — —
Research Site Lauderdale Lakes Florida — —
Research Site Miami Florida — —
Research Site Marietta Georgia — —
Research Site Woodstock Georgia — —
Research Site Chicago Illinois — —
Research Site Newton Kansas — —
Research Site Wichita Kansas — —
Research Site Lexington Kentucky — —
Research Site Frederick Maryland — —
Research Site Boston Massachusetts — —
Research Site Troy Michigan — —
Research Site City of Saint Peters Missouri — —
Research Site Kansas City Missouri — —
Research Site St Louis Missouri — —
Research Site Lincoln Nebraska — —
Research Site Las Vegas Nevada — —
Research Site Albuquerque New Mexico — —
Research Site Orchard Park New York — —
Research Site Rochester New York — —
Research Site Charlotte North Carolina — —
Research Site High Point North Carolina — —
Research Site Raleigh North Carolina — —
Research Site Salisbury North Carolina — —
Research Site Cincinnati Ohio — —
Research Site Cleveland Ohio — —
Research Site Duncansville Pennsylvania — —
Research Site Philadelphia Pennsylvania — —
Research Site Charleston South Carolina — —
Research Site Mt. Pleasant South Carolina — —
Research Site Rapid City South Dakota — —
Research Site Knoxville Tennessee — —
Research Site Austin Texas — —
Research Site Bedford Texas — —
Research Site Houston Texas — —
Research Site San Angelo Texas — —
Research Site Layton Utah — —
Research Site Arlington Virginia — —
Research Site Charlottesville Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02951026, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 17, 2020 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02951026 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →